Pathogen testing service | cdr labs
CPT CodeDescription
87529x2 Herpes Simple Virus 1 & 2

Globally, over 4.1 billion people are infected with HSV-1 and HSV-2 and the signs and symptoms can overlap.1 It is only through laboratory tests that these subtypes can be differentiated, which is important for managing herpes infections and identifying the risk of transmission to neonates and among sex partners.2,3

NAATs, such as the CDR Labs HSV 1 & 2 assay, are recommended by the CDC and WHO for HSV diagnosis. They are increasingly preferred over viral culture to diagnose genital herpes due to higher sensitivity, ease of specimen collection and transportation and faster results.2,3 Our HSV 1 & 2 assay distinguishes between HSV-1 and HSV-2 with significant reduction in hands-on time for laboratory professionals leading to faster results for our patients.4

References:

  1. WHO. Herpes simplex virus. World Health Organization. Last reviewed May 1, 2020. Accessed. September 10, 2021. https://www.who.int/news-room/fact-sheets/detail/herpes-simplex-virus.
  2. WHO. WHO guidelines For The Treatment of Genital Herpes Simplex Virus. World Health Organization. Last reviewed March 11, 2016. Accessed September 10, 2021. https://www.who.int/publications/i/item/978924154987
  3. Workowski, et al. Sexually Transmitted Infections Treatment Guidelines 2021. MMWR Recomm Rep 2021;70.  
  4. Aptima HSV 1 & 2 assay. US package insert AW-15346-001. Hologic, Inc., 2019.